store at low temperature
store at -80°C
Rosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3). Rosmantuzumab has potential antitumor activity and can be used to study advanced relapsed refractory solid tumors.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 289.00 | |
5 mg | In stock | $ 755.00 | |
10 mg | In stock | $ 1,180.00 | |
25 mg | In stock | $ 1,780.00 | |
50 mg | In stock | $ 2,390.00 | |
100 mg | In stock | $ 3,250.00 |
Description | Rosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3). Rosmantuzumab has potential antitumor activity and can be used to study advanced relapsed refractory solid tumors. |
In vivo |
Rosmantuzumab (25 mg/kg; intraperitoneal injection; once a week; for 4 weeks) significantly protects animals from developing liver fibrosis[1]. Rosmantuzumab (25 mg/kg; intraperitoneal injection; once every two weeks; for 6 weeks) in a bleomycin-induced pulmonary fibrosis mouse model significantly inhibits skin thickness, collagen deposition, and the number of α-SMA-positive cells[1]. |
Synonyms | OMP-131R10 |
Molecular Weight | N/A |
CAS No. | 1684393-04-1 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rosmantuzumab 1684393-04-1 Others OMP-131R10 inhibitor inhibit